{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T11:07:44Z","timestamp":1785582464439,"version":"3.56.0"},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2020,12,25]],"date-time":"2020-12-25T00:00:00Z","timestamp":1608854400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,5,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>\u2002<\/jats:title>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>OBJECTIVES<\/jats:title>\n                  <jats:p>Neuroendocrine thymic tumours (NETTs) are a distinct subgroup of rare malignancies. An international, multicentre retrospective analysis was used to study the clinicopathological features, current pattern of diagnosis, treatment and outcomes of patients with NETT.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>METHODS<\/jats:title>\n                  <jats:p>One hundred and forty-six NETT treated from 1989 to 2016 at 21 centres in China, Europe and North America were retrospectively collected and reclassified according to the World Health Organization histological type and International Thymic Malignancy Interest Group (ITMIG)\/International Association for Studies in Lung Cancer (IASLC)\/Union for International Cancer Control (UICC) staging. Clinicopathological features, diagnostic and therapeutic approaches and outcomes were investigated. Results in the earlier and latter halves of the study period were also compared.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>The pretreatment work-up relied exclusively on computed tomography in 85.6% (125\/146) of cases. Most patients had advanced disease, with 32.2% (47\/146) having lymph node involvement. Higher-grade histological type was associated with more advanced disease (P\u2009&amp;lt;\u20090.05). Induction therapies and surgical procedures were used more often in the latter half of the study. However, the complete resection rate remained unchanged, being 71.5% (98\/137) in the whole group. Complete resection was associated with significantly longer 5-year overall survival (77.2% vs 51.2%; P\u2009&amp;lt;\u20090.001) than incomplete or no resection. Significant survival differences were seen with the T, N and M categories of ITMIG\/IASLC\/UICC staging. Poorly differentiated carcinoma, ITMIG\/IASLC\/UICC stage IIIa or above and incomplete or no resection were independent risk factors for worse survival. No survival difference was noted between the earlier and the latter halves of the study (58.2% vs 71.9%; P\u2009=\u20090.299).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>Current management similar to that for thymomas is unsatisfactory in providing disease control or long-term survival for patients with NETT. Specific diagnostic tools and novel therapeutic agents are needed to improve management outcomes of this disease.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ejcts\/ezaa453","type":"journal-article","created":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T12:33:19Z","timestamp":1606221199000},"page":"1004-1013","source":"Crossref","is-referenced-by-count":15,"title":["Clinicopathological features and current treatment outcomes of neuroendocrine thymic tumours"],"prefix":"10.1093","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6517-9975","authenticated-orcid":false,"given":"Wentao","family":"Fang","sequence":"first","affiliation":[{"name":"Department of Thoracic Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier Luigi","family":"Filosso","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, San Giovanni Battista Hospital, University of Torino, Torino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja C","family":"Roden","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhitao","family":"Gu","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6842-9346","authenticated-orcid":false,"given":"Yuan","family":"Liu","sequence":"additional","affiliation":[{"name":"Statistics Center, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Agzarian","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, McMaster University Hospital, Hamilton, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert K","family":"Shen","sequence":"additional","affiliation":[{"name":"Division of General Thoracic Surgery, Mayo Clinic Rochester, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Ruffini","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, San Giovanni Battista Hospital, University of Torino, Torino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,12,25]]},"reference":[{"key":"2021050918070620100_ezaa453-B1","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1097\/SLA.0b013e3181dd4ec4","article-title":"Thymic neuroendocrine tumours: a SEER database analysis of 160 patients","volume":"251","author":"Gaur","year":"2010","journal-title":"Ann Surg"},{"key":"2021050918070620100_ezaa453-B2","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1002\/1097-0142(197204)29:4<1061::AID-CNCR2820290456>3.0.CO;2-3","article-title":"Mediastinal endocrine neoplasm of probable thymic origin related to carcinoid tumour: clinicopathologic study of 8 cases","volume":"29","author":"Rosai","year":"1972","journal-title":"Cancer"},{"key":"2021050918070620100_ezaa453-B3","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1309\/3PDN-PMT5-EQTM-H0CD","article-title":"Neuroendocrine carcinomas (carcinoid tumour) of the thymus: a clinicopathologic analysis of 80 cases","volume":"114","author":"Moran","year":"2000","journal-title":"Am J Clin Pathol"},{"key":"2021050918070620100_ezaa453-B4","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1097\/JTO.0000000000000663","article-title":"Introduction to the 2015 World Health Organization classification of tumours of the lung, pleura, thymus, and heart","volume":"10","author":"Travis","year":"2015","journal-title":"J Thorac Oncol"},{"key":"2021050918070620100_ezaa453-B5","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0022-5223(96)70409-9","article-title":"Thymic neuroendocrine carcinoma (carcinoid): a clinicopathologic study of fourteen cases","volume":"111","author":"de Montpr\u00e9ville","year":"1996","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2021050918070620100_ezaa453-B6","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0003-4975(98)01063-7","article-title":"Thymic neuroendocrine tumour (thymic carcinoid): a clinicopathologic study in 15 patients","volume":"67","author":"Fukai","year":"1999","journal-title":"Ann Thorac Surg"},{"key":"2021050918070620100_ezaa453-B7","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/S0003-4975(01)03032-6","article-title":"Neuroendocrine tumours of the thymus: a clinicopathological and prognostic study","volume":"72","author":"Gal","year":"2001","journal-title":"Ann Thorac Surg"},{"key":"2021050918070620100_ezaa453-B8","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/gcc.22183","article-title":"Tumour genetics and survival of thymic neuroendocrine neoplasms: a multi-Institutional clinicopathologic study","volume":"53","author":"Strobel","year":"2014","journal-title":"Genes Chromosomes Cancer"},{"key":"2021050918070620100_ezaa453-B9","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jtcvs.2014.08.061","article-title":"Outcome of primary neuroendocrine tumours of the thymus: a joint analysis of the International Thymic Malignancy Interest Group and the European Society of Thoracic Surgeons databases","volume":"149","author":"Filosso","year":"2015","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2021050918070620100_ezaa453-B10","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.athoracsur.2016.07.050","article-title":"Neuroendocrine tumours of the thymus: analysis of factors affecting survival in 254 patients","volume":"103","author":"Sullivan","year":"2017","journal-title":"Ann Thorac Surg"},{"key":"2021050918070620100_ezaa453-B11","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1097\/JTO.0000000000000290","article-title":"The IASLC\/ITMIG thymic epithelial tumours staging project: proposal for an evidence-based stage classification system for the forthcoming (8th) edition of the TNM classification of malignant tumours","volume":"9","author":"Detterbeck","year":"2014","journal-title":"J Thorac Oncol"},{"key":"2021050918070620100_ezaa453-B12","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/pst.1612","article-title":"Adjusting for centre heterogeneity in multicentre clinical trials with a time-to-event outcome","volume":"13","author":"Munda","year":"2014","journal-title":"Pharm Stat"},{"key":"2021050918070620100_ezaa453-B13","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1097\/JTO.0000000000000293","article-title":"The ITMIG\/IASLC thymic epithelial tumours staging project: a proposed lymph node map for thymic epithelial tumours in the forthcoming 8th edition of the TNM classification of malignant tumours","volume":"9","author":"Bhora","year":"2014","journal-title":"J Thorac Oncol"},{"key":"2021050918070620100_ezaa453-B14","doi-asserted-by":"crossref","first-page":"646","DOI":"10.21037\/jtd.2016.03.01","article-title":"CT staging and preoperative assessment of resectability for thymic epithelial tumours","volume":"8","author":"Shen","year":"2016","journal-title":"J Thorac Dis"},{"key":"2021050918070620100_ezaa453-B15","doi-asserted-by":"crossref","first-page":"711","DOI":"10.21037\/jtd.2016.02.07","article-title":"Postoperative survival for patients with thymoma complicating myasthenia gravis- preliminary retrospective results of the ChART database","volume":"8","author":"Wang","year":"2016","journal-title":"J Thorac Dis"},{"key":"2021050918070620100_ezaa453-B16","doi-asserted-by":"crossref","first-page":"30","DOI":"10.21037\/med.2018.03.19","article-title":"New options for neuroendocrine thymic tumours medical treatment","volume":"2","author":"Palmieri","year":"2018","journal-title":"Mediastinum"},{"key":"2021050918070620100_ezaa453-B17","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1093\/icvts\/ivx116","article-title":"Lymph node metastases in thymic malignancies: a Chinese Alliance for Research in Thymomas retrospective database analysis\u2020","volume":"25","author":"Gu","year":"2017","journal-title":"Interactive Cardiovascular and Thoracic Surgery"},{"key":"2021050918070620100_ezaa453-B18","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1097\/JTO.0000000000000660","article-title":"Impact of positive nodal metastases in patients with thymic carcinoma and thymic neuroendocrine tumours","volume":"10","author":"Weksler","year":"2015","journal-title":"J Thorac Oncol"},{"key":"2021050918070620100_ezaa453-B19","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.jtcvs.2018.04.049","article-title":"Lymph node metastasis in thymic malignancies: a Chinese multicenter prospective observational study","volume":"156","author":"Fang","year":"2018","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2021050918070620100_ezaa453-B20","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/ejcts\/ezx042","article-title":"Comparison of surgical approach and extent of resection for Masaoka-Koga Stage I and II thymic tumours in Europe, North America and Asia: an International Thymic Malignancy Interest Group retrospective database analysis","volume":"52","author":"Fang","year":"2017","journal-title":"Eur J Cardiothorac Surg"},{"key":"2021050918070620100_ezaa453-B21","doi-asserted-by":"crossref","first-page":"656","DOI":"10.21037\/jtd.2016.03.04","article-title":"Pretreatment biopsy for histological diagnosis and induction therapy in thymic tumours","volume":"8","author":"Yue","year":"2016","journal-title":"J Thorac Dis"},{"key":"2021050918070620100_ezaa453-B22","first-page":"345","article-title":"Treatment of neuroendocrine tumours: new recommendations based on the CLARINET study","volume":"19","author":"Kos-Kudla","year":"2015","journal-title":"Contemp Oncol (Pozn)"},{"key":"2021050918070620100_ezaa453-B23","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2147\/CMAR.S113382","article-title":"Emerging use of everolimus in the treatment of neuroendocrine tumours","volume":"9","author":"Gajate","year":"2017","journal-title":"Cancer Manag Res"},{"key":"2021050918070620100_ezaa453-B24","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1093\/annonc\/mdv252","article-title":"Pazopanib in pretreated advanced neuroendocrine tumours: a phase II, open-label trial of the Spanish Task Force Group for Neuroendocrine Tumours (GETNE)","volume":"26","author":"Grande","year":"2015","journal-title":"Ann Oncol"}],"container-title":["European Journal of Cardio-Thoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ejcts\/article-pdf\/59\/5\/1004\/37900502\/ezaa453.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ejcts\/article-pdf\/59\/5\/1004\/37900502\/ezaa453.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,9]],"date-time":"2021-05-09T18:08:04Z","timestamp":1620583684000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejcts\/article\/59\/5\/1004\/6048398"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,25]]},"references-count":24,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2020,12,25]]},"published-print":{"date-parts":[[2021,5,8]]}},"URL":"https:\/\/doi.org\/10.1093\/ejcts\/ezaa453","relation":{},"ISSN":["1010-7940","1873-734X"],"issn-type":[{"value":"1010-7940","type":"print"},{"value":"1873-734X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,5,1]]},"published":{"date-parts":[[2020,12,25]]}}}